Radiopaedia Helpers

Citation Syntax

error

"When reported, these lesions have a striking predilection for the intertrochanteric region of the femur (80-95%) ^1,6-8,11-12."

Line 13:117 · Citations are separated by commas, except when the range is over 2.

Spacing

error

"Cellular areas with spindle or stellated cells show immunoreactivity consistent with a bone-forming tumour (positive for smooth muscle actin and SATB2)¹¹.A GNAS p.Arg844Cys mutation has been identified, supporting the hypothesis that these tumours are part of the fibrous dysplasia spectrum, which also harbours GNAS mutations^10,11."

Line 27:177 · 'p.A' should have one space.

Headings Spacing

error

"Plain radiograph/CT "

Line 29:1 · Never put spaces at either end of headings.

List Punctuation

error

"if the lesion is aggressive/malignant (e.g. osteosarcoma) then management will be dictated by the histology and stage."

Line 49:127 · Do not put full stops at the end of a list item.

Litotes

warning

"This tumour has not found a permanent place in the WHO classification of soft tissue and bone tumours since its description in 1986. Currently (5^th edition, 2020) the term "liposclerosing myxofibrous tumour" does not have its own entry and merely appears as "no longer recommended" terminology within the diagnosis of fibrous dysplasia ¹⁰."

Line 3:235 · Consider using 'lack(s)' instead of 'not have'

Acronyms

warning

"Cellular areas with spindle or stellated cells show immunoreactivity consistent with a bone-forming tumour (positive for smooth muscle actin and SATB2)¹¹.A GNAS p.Arg844Cys mutation has been identified, supporting the hypothesis that these tumours are part of the fibrous dysplasia spectrum, which also harbours GNAS mutations^10,11."

Line 27:172 · 'GNAS' has no definition. Spell it out if it's unfamiliar to the audience.

"Cellular areas with spindle or stellated cells show immunoreactivity consistent with a bone-forming tumour (positive for smooth muscle actin and SATB2)¹¹.A GNAS p.Arg844Cys mutation has been identified, supporting the hypothesis that these tumours are part of the fibrous dysplasia spectrum, which also harbours GNAS mutations^10,11."

Line 27:328 · 'GNAS' has no definition. Spell it out if it's unfamiliar to the audience.

Headings Valid

warning

Expected headings

H1 Terminology
H1 Usage
H1 Epidemiology
H2 Risk factors
H2 Associations
H1 Clinical presentation
H2 Complications
H1 Diagnosis
H2 Diagnostic criteria
H2 Diagnostic clues
H1 Pathology
H2 Aetiology
H2 Location
H2 Classification
H2 Macroscopic appearance
H2 Microscopic appearance
H2 Immunophenotype
H2 Markers
H2 Genetics
H1 Radiographic features
H2 Plain radiograph
H2 Mammography
H2 Antenatal ultrasound
H2 Transoesophageal echocardiography
H2 Ultrasound
H2 CT
H3 Dual-energy CT
H2 Angiography (DSA)
H2 MRI
H2 CT/MRI
H2 Nuclear medicine
H3 PET-CT
H3 PET-MRI
H1 Radiology report
H1 Treatment and prognosis
H2 Complications
H1 History and etymology
H1 Differential diagnosis
H2 Clinical differential diagnosis
H1 Practical points
H1 See also

"Plain radiograph/CT "

Line 29:1 · "Plain radiograph/CT " is not a recognised heading for this article type.

Recency

suggestion

"This tumour has not found a permanent place in the WHO classification of soft tissue and bone tumours since its description in 1986. Currently (5^th edition, 2020) the term "liposclerosing myxofibrous tumour" does not have its own entry and merely appears as "no longer recommended" terminology within the diagnosis of fibrous dysplasia ¹⁰."

Line 3:144 · Avoid describing evidence as recent; give a date instead: 'Currently'.

Commas

suggestion

"The tumour comprises a wide mixture of tissues of histological elements, including lipomatous, fibroxanthomatous, myxomatous, and myxofibromatous components ⁵ and is not a universally accepted pathological entity, most likely falling within a spectrum of manifestations of fibrous dysplasia, and is classified as such in the current (5th edition, 2020) WHO classification of soft tissue and bone tumours ^3,10,11."

Line 11:75 · More than 5 commas in a single sentence might make it more difficult to read.

Biographical Lifespan

suggestion

"History and etymology"

Line 52:1 · A bold element in the History and etymology section should be a person; it would be useful to have their lifespan details: '<h4>History and etymology</h4> <p>The term "liposclerosing myxofibrous tumour" was first proposed and introduced in 1986 by the American pathologists, <strong>Bruce D. Ragsdale</strong> '

Lint: liposclerosing-myxofibrous-tumour-1